BackKalVista Pharmaceuticals Overview
KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals Target Price

Analysts' 12-month price predictions for KALV.

Get informed when a big investor buys or sells

+ Follow

Share Price

$27

Average Target Price

$27.000% upside

2 analysts in the last 4 months

High: $27 | Low: $27

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-01H.C. WainwrightAndrew Fein$270% upsideOpen
2026-04-29Leerink Partners$270% upsideOpen
2026-01-09H.C. WainwrightAndrew Fein$3737% upsideOpen
2026-01-06Needham$3218.5% upsideOpen
2025-11-11JMP Securities$283.7% upsideOpen
2024-11-05NeedhamSerge Belanger$283.7% upsideOpen
2024-09-06H.C. WainwrightAndrew Fein$2025.9% downsideOpen
2024-09-06Leerink PartnersJoseph Schwartz$2025.9% downsideOpen
2022-07-08Needham$3840.7% upsideOpen